Microbix Biosystems Inc. MBX.TO
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 50.91% | -7,340.97% | -236.75% | -433.02% | -758.51% |
| Total Depreciation and Amortization | 6.00% | 13.28% | -2.70% | 66.11% | 3.11% |
| Total Amortization of Deferred Charges | -- | -- | -- | -75.22% | -- |
| Total Other Non-Cash Items | 3.85% | 20.17% | 8.98% | 7.01% | 131.38% |
| Change in Net Operating Assets | 57.10% | 32.89% | -179.37% | 344.16% | -267.09% |
| Cash from Operations | 75.74% | -132.40% | -429.63% | -89.14% | -235.56% |
| Capital Expenditure | 75.41% | 5.03% | 15.78% | 33.45% | 73.70% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 75.41% | 5.03% | 15.78% | 33.45% | 80.80% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -370.32% | 87.75% | 6.15% | 6.28% | 82.51% |
| Issuance of Common Stock | -- | -- | -- | -100.00% | -- |
| Repurchase of Common Stock | 21.56% | 74.80% | 66.03% | 33.87% | -64.02% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -43.31% | -1,100.38% | 51.79% | 121.32% | 32.07% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 60.12% | -242.30% | -3,674.88% | -92.41% | -3,648.94% |